Blood News and Research

RSS

Nova Biomedical's subsidiary Sanvita CBGM to acquire assets of CCS Medical's subsidiary, Sanvita Inc

Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today announced that they have reached a definitive agreement under which Nova Biomedical's independent, wholly owned subsidiary, Sanvita CBGM, LLC, will acquire certain assets of Sanvita, Inc., a wholly-owned subsidiary of CCS Medical. Sanvita, Inc. is currently the exclusive distributor of Nova's "NovaMax" consumer blood glucose product line in the United States.

11 Sep 2009

Wisconsin researchers identify the genetic region responsible for cardiovascular collapse during anesthesia

Researchers at The Medical College of Wisconsin in Milwaukee have identified the genetic region in rats responsible for cardiovascular collapse during anesthesia. While it is well known that people have different cardiovascular sensitivity to anesthesia causing some to collapse even when low doses are administered, the mechanism responsible for this susceptibility is not clear.

11 Sep 2009

Newly established Edward Neurosciences Institute to provide advanced stroke care in Chicago

Edward Hospital announced today that it has established the Edward Neurosciences Institute in affiliation with the Northwestern Medical Faculty Foundation to bring the highest level of stroke care in the world to the west and southwest suburbs of Chicago.

11 Sep 2009

Researchers discover the role of endothelin in vaso-occlusive pain

Agonizing physical pain, known as vaso-occlusive pain, can afflict children who have sickle cell disease (SCD). In some cases infants as young as two months of age suffer vaso-occlusive pain so severe that opiate medications and hospitalizations are their only relief. Researchers believe vaso-occlusion is caused by a blockage of the blood vessels that occurs when sickle shaped red cells attempt to pass through the round blood vessels.

11 Sep 2009

KidneyTel system helps manage health issues faced by kidney patients

Kidney patients often have a number of serious chronic health issues in addition to their kidney disease. Fresenius Medical Care, the world’s leading renal therapies company, has developed the KidneyTel system to provide an integrated care solution to assist patients, their families and their providers in managing the full range of health issues that kidney patients face on a daily basis.

11 Sep 2009

Routine screening is useful for identifying pregnant women with gestational diabetes

Pregnant women who develop marked increased blood sugar levels during pregnancy can reduce the risk of certain birth complications if they receive treatment. This is a prerequisite for offering all pregnant women routine screening for gestational diabetes.

11 Sep 2009

SafeTrace Tx software deployed in Schuylkill Health of Pottsville

Global Med Technologies((R)), Inc. ("Global Med" or the "Company"), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies division has licensed and deployed its SafeTrace Tx((R)) transfusion management software to Schuylkill Health of Pottsville, Pennsylvania.

11 Sep 2009

Blood collection professionals honored as part of the 5th Annual Blood Collectors Week

Blood collection professionals will be recognized in communities worldwide September 13-19, 2009, as part of the 5th Annual Blood Collectors Week, sponsored jointly by Fenwal, Inc. and AABB (formerly known as the American Association of Blood Banks). During the week, blood centers across the country will host celebrations, often with local government officials, to recognize their staffs and donors.

11 Sep 2009

Phase II human clinical trial of Exsulin commences

Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin, a peptide drug product aimed at restoring insulin production in people with diabetes mellitus. The randomized, controlled 12-week trial in patients with established Type 1 diabetes (T1DM) will be co-led by Mayo Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, Canada.

10 Sep 2009

Endothelin research update to be presented at APS' 11th International Conference

Recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of pulmonary arterial hypertension and provides hope for treating other chronic diseases.

10 Sep 2009

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

By offering all children in Africa vaccines that protect against bacterial infections, researchers say the number of deaths among children living with sickle-cell anemia could be reduced, Reuters reports. An estimated 200,000 children in Africa annually are born with sickle-cell anemia, a genetic disease "in which red blood cells deform into a sickle shape and cluster, blocking blood flow and causing pain, vulnerability to infections and organ damage."

10 Sep 2009

Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.

10 Sep 2009

Cord Blood America to complete its new Las Vegas laboratory on schedule

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, said today that it is on schedule to complete the construction of its new Las Vegas laboratory by the first week of October.

10 Sep 2009

QIAGEN's new QIAsafe DNA blood products launched

Biomatrica, Inc. and QIAGEN announce the launch of QIAGEN's new QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica's innovative SampleMatrix(R) technology.

From QIAGEN Manchester Limited 10 Sep 2009

New treatment strategies for multiple sclerosis

The drawback in the new immunotherapies in multiple sclerosis (MS) includMe severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis.

10 Sep 2009

ThermoGenesis releases results for fourth quarter and fiscal year 2009

ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.

10 Sep 2009

Non-invasive CR-2000 Research System to be used in START clinical trial

Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.

10 Sep 2009

Blood News and Research

Nova Biomedical's subsidiary Sanvita CBGM to acquire assets of CCS Medical's subsidiary, Sanvita Inc

Wisconsin researchers identify the genetic region responsible for cardiovascular collapse during anesthesia

Newly established Edward Neurosciences Institute to provide advanced stroke care in Chicago

Researchers discover the role of endothelin in vaso-occlusive pain

KidneyTel system helps manage health issues faced by kidney patients

Routine screening is useful for identifying pregnant women with gestational diabetes

SafeTrace Tx software deployed in Schuylkill Health of Pottsville

Blood collection professionals honored as part of the 5th Annual Blood Collectors Week

Phase II human clinical trial of Exsulin commences

Endothelin research update to be presented at APS' 11th International Conference

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

Acceleron's Phase 1 trial of ACE-031 reveals its potential in treating neuromuscular diseases

Cord Blood America to complete its new Las Vegas laboratory on schedule

QIAGEN's new QIAsafe DNA blood products launched

New treatment strategies for multiple sclerosis

ThermoGenesis releases results for fourth quarter and fiscal year 2009

Non-invasive CR-2000 Research System to be used in START clinical trial

U.S patent for Tryton Side Branch Stent System

New form of malarial infection identified

Varying physical activity for optimal health benefits

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News